Cover |
12 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Document Information [Line Items] | |
| Document Type | S-4/A |
| Amendment Flag | true |
| Amendment Description | EXPLANATORY NOTE The issuances of (i) all InMed Common Shares in exchange for each share of Mentari Common Stock and Mentari Series A Preferred Stock (including shares of Mentari Common Stock issued in the Mentari Pre-Closing Financing), (ii) all InMed Warrants in exchange for Mentari Warrants (including Mentari Pre-Funded Warrants issued in the Mentari Pre-Closing Financing), (iii) all InMed Series A Preferred Shares in exchange for shares of Mentari Series Seed Preferred Stock, (iv) all options to purchase InMed Common Shares in exchange for Mentari Options, (v) all InMed RSUs in exchange for Mentari RSUs, (vi) all InMed Common Shares issuable upon exercise of InMed Warrants issued in exchange for Mentari Warrants, (vii) all InMed Common Shares issuable upon conversion of InMed Series A Preferred Shares issued in exchange for Mentari Series Seed Preferred Stock, (viii) all InMed Common Shares issuable upon exercise of options to purchase InMed Common Shares issued in exchange for Mentari Options, and (ix) all InMed Common Shares issuable upon settlement of InMed RSUs issued in exchange for Mentari RSUs, are intended to be covered by this registration statement on Form S-4 of which this proxy statement/prospectus is a part. There is no difference between (A) the InMed Common Shares that will be issued in exchange for each share of Mentari Common Stock and Mentari Series A Preferred Stock (including shares of Mentari Common Stock issued in the Mentari Pre-Closing Financing), (B) the InMed Common Shares that will be issuable upon the exercise of InMed Warrants issued in exchange for Mentari Warrants, (C) the InMed Common Shares that will be issuable upon conversion of InMed Series A Preferred Shares issued in exchange for each share of Mentari Series Seed Preferred Stock, (D) the InMed Common Shares that will be issuable upon the exercise of options to purchase InMed Common Shares issued in exchange for Mentari Options, and (E) the InMed Common Shares that will be issuable upon the settlement of InMed RSUs that will be issued in exchange for Mentari RSUs. Capitalized terms used in this section but not defined are as defined elsewhere in this registration statement on Form S-4. |
| Entity Registrant Name | INMED PHARMACEUTICALS INC. |
| Entity Central Index Key | 0001728328 |
| Entity Incorporation, State or Country Code | A1 |
| Entity Filer Category | Non-accelerated Filer |
| Entity Tax Identification Number | 98-1428279 |
| Entity Small Business | true |
| Entity Emerging Growth Company | false |
| Entity Address, Address Line One | Suite 1800 – 510 |
| Entity Address, Address Line Two | West Georgia Street |
| Entity Address, City or Town | Vancouver |
| Entity Address, State or Province | BC |
| Entity Address, Postal Zip Code | V6B 0M3 |
| City Area Code | 604 |
| Local Phone Number | 669-7207 |
| Entity Primary SIC Number | 2834 |
| Business Contact [Member] | |
| Document Information [Line Items] | |
| Entity Registrant Name | Registered Agent Solutions, Inc. |
| Entity Address, Address Line One | 1100 H Street NW |
| Entity Address, Address Line Two | Suite 840 |
| Entity Address, City or Town | Washington |
| Entity Address, State or Province | DC |
| Entity Address, Postal Zip Code | 20005 |
| City Area Code | 888 |
| Local Phone Number | 705-7274 |